XML 58 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements - Condensed Consolidated Statement of Operations and Comprehensive loss (Details) - USD ($)
$ / shares in Units, $ in Thousands
2 Months Ended 5 Months Ended 7 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2023
Jul. 21, 2023
Dec. 31, 2022
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements        
Acquired in-process research and development $ 348,000 $ 348,000    
Total operating costs and expenses 283,714 318,442 $ 29,644 $ 48,429
Income (loss) from operations (283,714) (318,442) (29,644) (48,429)
Income (loss) before taxes (297,711) (323,954) (60,678) (52,556)
Net income (loss) and comprehensive income (loss) $ (297,711) $ (323,954) $ (60,678) $ (52,556)
Basic net loss per share (in dollars per share) $ (8.01) $ (8.72) $ (0.44) $ (0.38)
Diluted net loss per share (in dollars per share) $ (8.01) $ (8.72) $ (0.44) $ (0.38)
As Reported        
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements        
Total operating costs and expenses $ (64,286) $ (29,558)    
Income (loss) from operations 64,286 29,558    
Income (loss) before taxes 50,289 24,046    
Net income (loss) and comprehensive income (loss) $ 50,289 $ 24,046    
Basic net loss per share (in dollars per share) $ 1.35 $ 0.65    
Diluted net loss per share (in dollars per share) $ 1.35 $ 0.65    
Adjustment        
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements        
Acquired in-process research and development $ 348,000 $ 348,000    
Total operating costs and expenses 348,000 348,000    
Income (loss) from operations (348,000) (348,000)    
Income (loss) before taxes (348,000) (348,000)    
Net income (loss) and comprehensive income (loss) $ (348,000) $ (348,000)    
Basic net loss per share (in dollars per share) $ (9.36) $ (9.37)    
Diluted net loss per share (in dollars per share) $ (9.36) $ (9.37)    
Restatement adjustment | Error correction of write off of acquired in process research and development        
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements        
Net income (loss) and comprehensive income (loss) $ 348,000 $ 348,000